Agilent Technologies Inc.

Agilent Technologies Inc.

A Stock Report Card





Score: 100/100


A returned -0.98% in the last 12 months. Based on the other stocks in it's sector with an average return of -31.76%, it's performance is above average giving it a grade of 100 of 100.


Score: 78/100


18 analysts offer 12-month price forecasts for A. Together, they have an average target of 167.75, the most optimistic forecast put A at 170 within 12-months and the most pessimistic has A at 161.


Score: 68/100


A had a bullish sentiment score of 68.33% across Twitter and StockTwits over the last 12 months. It had an average of 131.51 posts, 644.62 comments, and 2,019.81 likes per day.


Score: 29/100


A receieves a 28 of 100 based on 14 indicators. 3 are bullish, 9 are bearish.


Score: 10/100


A has missed earnings 10 times in the last 20 quarters.


Score: 48/100


A has had a lower than average amount of volatility over the last 12 months giving it a grade of 48 of 100.


Score: 47/100


A's most recent dividend was $0.15 per share, based on a share price of $133.85. It was a payout ratio of 23.41% compared to their total earnings.

Agilent Technologies Inc. Summary

New York Stock Exchange / A
Diagnostics & Research
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
pluto logo
Los Angeles, CA